Takeda’s €40m expansion will bring 40 new jobs to west Dublin
Takeda takes a patient-first approach to the development of its cancer treatment drugs. Image: Way Home Studio/Shutterstock

Takeda’s €40m expansion will bring 40 new jobs to west Dublin

5 Dec 2016

Japan’s largest pharmaceutical company Takeda is to create 40 new jobs at a new facility in Grangegorman, as part of a €40m investment.

Takeda first set up operations in Ireland in 1997, manufacturing products for global markets. In 2002, Takeda chose Dublin as the location for its first active pharmaceutical ingredient facility outside of Japan.

The company will expand its existing footprint at Grange Castle with the construction of a new stand-alone high-containment production facility dedicated to manufacturing its oncology product NINLAROTM for global markets. The investment will create approximately 40 new jobs.

‘Ireland is globally recognised as a centre of excellence in life sciences due to the country’s regulatory track record and talent availability’
– MARTIN SHANAHAN

The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.

A patient-first philosophy

Paul Keogh, plant director at Takeda Ireland, Grange Castle, said that the additional investment in Ireland demonstrates the confidence and commitment Takeda has in its Irish operation.

“We are delighted that Takeda has chosen Ireland for this investment and proud that we have been entrusted with the responsibility to produce and deliver this very important treatment for cancer patients worldwide. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site,” Keogh said.

Jobs Minister Mitchell O’Connor said that the pharma industry makes a huge contribution to the Irish economy in terms of jobs and exports, and is one of the fastest-growing sectors.

“Takeda’s decision to manufacture their new cancer treatment in Ireland is a great win and vote of confidence in Ireland, and it builds on our ongoing expansion of the sector here,” she added.

IDA Ireland CEO Martin Shanahan added: “Ireland is globally recognised as a centre of excellence in life sciences due to the country’s regulatory track record and talent availability.”

Looking for jobs in tech or science? Check out our Employer Profiles for information on companies hiring right now and sign up for our Career Republic e-zine for a weekly digest of sci-tech careers news and advice.

John Kennedy
By John Kennedy

John Kennedy is a journalist who served as editor of Silicon Republic for 17 years. His interests include all things technological, music, movies, reading, history, gaming and losing the occasional game of poker.

Loading now, one moment please! Loading